Literature DB >> 2952937

Atrial natriuretic peptide in patent ductus arteriosus.

S Andersson, I Tikkanen, E Pesonen, O Meretoja, M Hynynen, F Fyhrquist.   

Abstract

Plasma concentrations of atrial natriuretic peptide (ANP) were measured in nine infants (age 4 days-9 months) before and after closure of patent ductus arteriosus. Initially all patients had marked distention of the left atrium as indicated by a left atrium to aortic root ratio greater than or equal to 1.3 on echocardiography. After closure of the ductus, operative in six and pharmacological in three patients, left atrial size normalized (left atrium to aortic root ratio less than 1.3) in all patients, except in one treated surgically. Before closure the plasma concentration of ANP was 86-2224 pg/ml and after closure 44-1400 pg/ml. There was a significant correlation between the size of left atrium and plasma concentration of ANP (r = 0.56; p = 0.01). Our results suggest that in infants with patent ductus arteriosus the left atrium is the main source of ANP. The secretory rate of ANP decreases immediately after restoring left atrial size by closure of the ductus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952937     DOI: 10.1203/00006450-198704000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

Review 1.  Atrial natriuretic factor and neonatal body fluid homeostasis.

Authors:  G Karthikeyan; S Singhi
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

2.  Atrial natriuretic peptide and blood volume during red cell transfusion in preterm infants.

Authors:  W Rascher; N Lingens; M Bald; O Linderkamp
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 3.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.